
## Data

Private data from [The Health Improvement Network (THIN)](https://www.the-health-improvement-network.com/),[IQVIA Canada EMR Primary Care Data](https://www.iqvia.com/solutions/real-world-evidence/real-world-data-and-insights), and [Morris Kahn Maccabi Health Data Science Institut](https://www.ksminnovation.com/about/)

## Features

- `age`
- `gender`
- `BMI`
- `HbA1c`
- `glucose`

## Target

Diabetes defined as:

i) Glucose ≥126 mg/dL within 2 years or;
ii) HbA1c ≥ 6.5% within 2 years or;
iii) Glucose ≥200 mg/dL in a single measurement or;
iv) Diagnosed Diabetes or;
v) Initiating any glucose lowering agent other than metformin (which is often prescribed to pre-diabetic individuals) without prior fulfilment of the diabetes glycaemic criteria.
